Association for the Advancement of Restorative Medicine

The gut microbiome exerts significant influence over mental health through the bidirectional communication network of the gut–brain axis. Growing evidence implicates disruptions in gut microbial composition in the pathophysiology of a range of neuropsychiatric conditions, including anxiety, major depressive disorder (MDD), and schizophrenia. Psychobiotics have emerged as a promising adjunctive strategy for modulating mental health outcomes through several interconnected mechanisms, including neurotransmitter modulation, immune regulation, short-chain fatty acid production, and hypothalamic–pituitary–adrenal axis stabilization, among others. This narrative review, intended for clinicians and researchers in integrative and functional medicine, synthesizes current clinical and translational evidence for probiotic interventions across anxiety, MDD, bipolar disorder, and schizophrenia, highlighting key strains, mechanisms, and outcomes. Findings demonstrate that specific Lactobacillus and Bifidobacterium strains show measurable benefit in reducing anxiety and depressive symptom severity, while emerging evidence suggests potential utility in psychotic disorders. Limitations include significant heterogeneity in strain selection, dosing protocols, study populations, and outcome measures, which constrain clinical translation. Future research should prioritize standardized protocols, longitudinal designs, and functional microbiome profiling to support personalized, microbiome-informed approaches to mental health care.

With over one in five U.S. adults facing a diagnosable psychiatric condition, mental health remains a critical frontier in integrative care. However, pharmacological management often falters; nearly 50% of patients discontinue medication due to intolerable side effects like weight gain and emotional blunting. This guide bridges that gap, utilizing a robust body of clinical evidence — from double-blind RCTs to mechanistic studies — to demonstrate how specific botanicals and amino acids can effectively modulate neurotransmitter systems with a significantly lower adverse effect burden.

Iodine is an indispensable component in the biosynthesis of the thyroid hormones thyroxine (T4, prohormone) and triiodothyronine (T3, active hormone). Iodine must be obtained through the diet, as the body is unable to produce it. The risks posed by iodine deficiency are well recognized, but more widespread use of biomarkers for iodine status has demonstrated that iodine deficiency is still evident within subpopulations in high income countries, including areas with low goiter prevalence, and even in regions where iodine deficiency was considered eradicated.